跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FEMARA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FEMARA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
FEMARA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Novartis Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 12, 2022
Approval ID
5136c788d4c0cbd3
Company
Novartis Pharma Gmbh
Type
Standard
Approval Details
Approval Id
5136c788d4c0cbd3
Drug Cima Aemps Name
FEMARA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
20020268
Holder Company Name
Novartis Pharma Gmbh
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/novartis-pharma-gmbh
Authorization Date
2022-01-12
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2.5 mg de letrozol
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Novartis Pharma Gmbh
Company Detail Path
/organization/novartis-pharma-gmbh
Company Information
Pharmaceutical Company Name
Novartis Pharma GmbH
Country Name
Austria
City Name
nürnberg,bayern,country_de
Address
Roonstr. 25
Website
http://www.novartis.at
Active Ingredients
LETROZOL
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 12, 2022
Approval ID
5136c788d4c0cbd3
Type
Standard
Back to CIMA-AEMPS Approvals
